Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a malaria drug ease lingering lyme symptoms?

NCT ID NCT07230028

First seen Nov 17, 2025 · Last updated Jun 23, 2026 · Updated 31 times

Summary

This study tests whether adding hydroxychloroquine (a malaria drug) to standard doxycycline treatment can reduce long-term physical complaints in adults with Lyme disease. Fifty participants will take either hydroxychloroquine or a placebo twice daily for 28 days, then be followed for a year. The main goal is to see if the combination improves quality of life compared to doxycycline alone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LYME BORRELIOSIS, NERVOUS SYSTEM are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Hydroxychloroquine (Plaquenil) added to doxycycline

What this could lead to

If it works, this could point toward a better treatment for lingering Lyme symptoms that don't go away with standard antibiotics alone.

What could go wrong

This is a small pilot study with only 50 people, so results may not apply widely. Hydroxychloroquine can have side effects like vision problems or heart issues, and the drug may not help at all.

Conditions

The condition(s) this trial relates to.

Lyme disease Lyme Neuroborreliosis post-treatment Lyme disease syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.